Lantheus Holdings, Inc. (LNTH)

Nasdaq · Healthcare · Drug Manufacturers - Specialty & Generic
$102.10+0.00%As of 2026-11-22 · USD
Last session low $102.07Last session high $102.40
52-week low $54.9452-week high $111.86
Market cap
$6.68B
Sector
Healthcare
P/E (TTM)
25.4x

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in USD.

IndicatorValueReading
RSI (14)70.2In the overbought range (above 70)
MACD (12, 26, 9)0.48Above its signal line (0.36); histogram 0.12
Bollinger %B (20, 2)86%Inside the bands (99.65 to 102.50)
SMA 20101.07Price is 1.0% above
SMA 50100.47Price is 1.6% above
SMA 20094.00Price is 8.6% above
ATR (20)0.49% of priceAverage true range per day
52-week position83%In the upper part of the 54.94 to 111.86 range

About Lantheus Holdings, Inc.

Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in diagnosis and treatment of heart, cancer, and other diseases worldwide.

Latest fiscal yearEnded 2025-12-31: revenue of $1.54B and an operating margin of 20.5%.

More in Drug Manufacturers - Specialty & Generic